Lexicon Pharmaceuticals (LXRX) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.22
-0.19
-0.16
-0.13

Details

Expected EPS
-0.17
Actual EPS
-0.22
Surprise EPS
-0.05
Surprise Percent
+29.41%

Description

Lexicon Pharmaceuticals (LXRX) has reported earnings of -0.22 per share for Q2 2023.

0 Comments

Share your thoughts